The Progressive Phenotype of Non-IPF ILD: Clinical Relevance and Identification
Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic ConfidenceПодробнее
How to Identify Progressive Fibrosing ILDПодробнее
Early Identification of Progressive Chronic Fibrosing ILDПодробнее
Signs of Chronic Fibrosing ILD With Progressive PhenotypeПодробнее
Recognizing Chronic Fibrosing Interstitial Lung Disease and The Impact of COVID-19 on Clinical CareПодробнее
Diagnosis: Chronic Fibrosing ILD with Progressive PhenotypeПодробнее
Progressive Fibrotic ILD | Kevin Flaherty, MD, MSПодробнее
Recognizing Chronic Fibrosing Interstitial Lung Diseases With a Progressive PhenotypeПодробнее
New Prospects for Diagnosis and Prognosis (ILD/IPF)Подробнее
Putting Clinical Research Into Practice: Exacerbations, Progressive Phenotypes, and MoreПодробнее
The Clinical Importance of Interstitial Lung AbnormalitiesПодробнее
Diagnosis and Management of Progressive Pulmonary Fibrosis (PPF)Подробнее
Should Unclassifiable ILD be Treated like IPF? | Joao A. de Andrade, MDПодробнее
Expanding Our Clinical Understanding of ILD | PFF Summit 2021Подробнее
Chronic Fibrosing ILD With Progressive PhenotypeПодробнее
Dr. Ayodeji Adegunsoye - Predicting disease progression and outcomes in ILDПодробнее
Treatment: Chronic Fibrosing ILD with Progressive PhenotypeПодробнее
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical AdvancesПодробнее
PF-ILD Treatment efficacy based on disease severity and with progressive phenotypeПодробнее
Critical Advancements: Improving ILD Diagnosis and Predicting Clinical ProgressionПодробнее
